C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors Invests $691,000 in The Cooper Companies, Inc. (NASDAQ:COO)

C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors acquired a new stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 6,970 shares of the medical device company’s stock, valued at approximately $691,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Fulton Bank N.A. grew its holdings in shares of Cooper Companies by 3.0% during the fourth quarter. Fulton Bank N.A. now owns 3,718 shares of the medical device company’s stock valued at $342,000 after purchasing an additional 109 shares during the last quarter. Mather Group LLC. boosted its position in Cooper Companies by 7.4% during the 4th quarter. Mather Group LLC. now owns 1,926 shares of the medical device company’s stock valued at $177,000 after purchasing an additional 133 shares during the period. MassMutual Private Wealth & Trust FSB boosted its position in Cooper Companies by 15.6% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,008 shares of the medical device company’s stock valued at $93,000 after purchasing an additional 136 shares during the period. Greenleaf Trust grew its stake in Cooper Companies by 5.0% during the 4th quarter. Greenleaf Trust now owns 2,915 shares of the medical device company’s stock worth $268,000 after buying an additional 139 shares during the last quarter. Finally, UMB Bank n.a. increased its position in Cooper Companies by 22.5% in the fourth quarter. UMB Bank n.a. now owns 773 shares of the medical device company’s stock worth $71,000 after buying an additional 142 shares during the period. Institutional investors and hedge funds own 24.39% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on COO shares. Wells Fargo & Company upped their price target on shares of Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a research report on Friday, December 6th. StockNews.com lowered shares of Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday, December 11th. Citigroup cut their price target on Cooper Companies from $116.00 to $115.00 and set a “buy” rating on the stock in a report on Friday, December 6th. Morgan Stanley decreased their price objective on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a report on Friday, December 6th. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of Cooper Companies in a research note on Friday, December 6th. Three equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $117.00.

Cooper Companies Stock Performance

Shares of NASDAQ COO opened at $86.46 on Thursday. The Cooper Companies, Inc. has a 1 year low of $84.76 and a 1 year high of $112.38. The firm has a market cap of $17.26 billion, a P/E ratio of 44.34, a PEG ratio of 2.23 and a beta of 1.00. The stock has a fifty day moving average price of $93.23 and a two-hundred day moving average price of $99.65. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91.

Cooper Companies (NASDAQ:COO) last announced its earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share for the quarter, beating the consensus estimate of $1.00 by $0.04. The business had revenue of $1.02 billion during the quarter, compared to analysts’ expectations of $1.03 billion. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The company’s quarterly revenue was up 9.8% on a year-over-year basis. During the same quarter last year, the business posted $0.87 earnings per share. Research analysts forecast that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.